The Food and Drug Administration (FDA) in the U.S. has authorized the first approved drug for a rare form of motor neuron disease (MND) based on the results of a Phase 3 clinical trial completed at the University of Sheffield, ...
May 1, 2023
0
7
A new technology called the Pipeline embolization device (PED) shows encouraging results in patients with certain types of difficult-to-treat brain aneurysms, reports the December issue of Neurosurgery, official journal of ...
Dec 3, 2012
0
0
For parents with questions about COVID-19 vaccines and children, Johns Hopkins Medicine experts offer answers.
Feb 15, 2021
0
2
(HealthDay)—Use of the word "breakthrough" in the U.S. Food and Drug Administration's expedited approval process could mislead doctors about the new drugs' actual benefits, researchers warn.
Apr 12, 2016
0
2
(HealthDay)—A Florida stem cell clinic has received a warning letter from the U.S. Food and Drug Administration about what the agency describes as serious problems that could pose health risks to patients.
Aug 29, 2017
0
0
U.S. health officials on Wednesday approved the first pill made from healthy bacteria found in human waste to fight dangerous gut infections—an easier way of performing so-called fecal transplants.
Apr 27, 2023
0
5
Federal health regulators issued a negative review Monday of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, after months of lobbying by patient advocates urging approval.
Mar 28, 2022
0
11
Many physicians are unfamiliar with how the Food and Drug Administration's (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals are more rigorous than ...
Jan 9, 2024
0
0
Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy ...
Jul 9, 2014
1
0
New research questions the effectiveness of the U.S. Food and Drug Administration's accelerated drug approval program after finding that many cancer drugs remain unproven five years later.
Apr 8, 2024
0
2
